GTHX Annual EBIT
-$34.81 M
+$100.61 M+74.29%
31 December 2023
Summary:
As of February 2, 2025, GTHX annual earnings before interest & taxes is -$34.81 million, with the most recent change of +$100.61 million (+74.29%) on December 31, 2023. During the last 3 years, it has risen by +$61.25 million (+63.76%).GTHX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly EBIT
-$2.74 M
+$5.50 M+66.72%
30 June 2024
Summary:
As of February 2, 2025, GTHX quarterly earnings before interest & taxes is -$2.74 million, with the most recent change of +$5.50 million (+66.72%) on June 30, 2024. Over the past year, it has dropped by -$15.47 million (-121.55%).GTHX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX TTM EBIT
-$34.02 M
-$15.47 M-83.41%
30 June 2024
Summary:
As of February 2, 2025, GTHX TTM earnings before interest & taxes is -$34.02 million, with the most recent change of -$15.47 million (-83.41%) on June 30, 2024. Over the past year, it has increased by +$29.22 million (+46.20%).GTHX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +74.3% | -121.5% | +46.2% |
| 3 y3 years | +63.8% | -121.5% | +46.2% |
| 5 y5 years | +59.2% | +91.1% | +73.8% |
GTHX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +126.3% | -121.6% | +472.1% |
G1 Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.74 M(-66.7%) | -$34.02 M(+83.4%) |
| Mar 2024 | - | -$8.24 M(+5.0%) | -$18.55 M(-46.7%) |
| Dec 2023 | -$34.81 M(-74.3%) | -$7.85 M(-48.3%) | -$34.81 M(-39.1%) |
| Sept 2023 | - | -$15.18 M(-219.3%) | -$57.13 M(-9.7%) |
| June 2023 | - | $12.73 M(-151.9%) | -$63.24 M(-44.0%) |
| Mar 2023 | - | -$24.51 M(-18.8%) | -$113.01 M(-16.6%) |
| Dec 2022 | -$135.43 M(-5.1%) | -$30.17 M(+41.7%) | -$135.43 M(-5.3%) |
| Sept 2022 | - | -$21.29 M(-42.5%) | -$142.97 M(-12.2%) |
| June 2022 | - | -$37.04 M(-21.1%) | -$162.90 M(-0.8%) |
| Mar 2022 | - | -$46.93 M(+24.4%) | -$164.13 M(+15.0%) |
| Dec 2021 | -$142.76 M(+48.6%) | -$37.72 M(-8.5%) | -$142.76 M(+10.5%) |
| Sept 2021 | - | -$41.21 M(+7.7%) | -$129.16 M(+31.9%) |
| June 2021 | - | -$38.27 M(+49.8%) | -$97.93 M(+8.1%) |
| Mar 2021 | - | -$25.56 M(+6.0%) | -$90.60 M(-5.7%) |
| Dec 2020 | -$96.07 M | -$24.11 M(+141.5%) | -$96.07 M(-10.5%) |
| Sept 2020 | - | -$9.99 M(-67.7%) | -$107.39 M(-17.2%) |
| June 2020 | - | -$30.95 M(-0.3%) | -$129.77 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$31.02 M(-12.5%) | -$129.52 M(+4.1%) |
| Dec 2019 | -$122.45 M(+43.6%) | -$35.44 M(+9.5%) | -$124.38 M(+12.0%) |
| Sept 2019 | - | -$32.36 M(+5.5%) | -$111.02 M(+11.6%) |
| June 2019 | - | -$30.69 M(+18.6%) | -$99.48 M(+10.0%) |
| Mar 2019 | - | -$25.88 M(+17.2%) | -$90.44 M(+6.0%) |
| Dec 2018 | -$85.29 M(+39.9%) | -$22.09 M(+6.1%) | -$85.29 M(+6.0%) |
| Sept 2018 | - | -$20.82 M(-3.8%) | -$80.48 M(+6.5%) |
| June 2018 | - | -$21.65 M(+4.5%) | -$75.59 M(+9.1%) |
| Mar 2018 | - | -$20.73 M(+19.9%) | -$69.31 M(+13.7%) |
| Dec 2017 | -$60.97 M(+100.6%) | -$17.28 M(+8.5%) | -$60.97 M(+12.7%) |
| Sept 2017 | - | -$15.93 M(+3.6%) | -$54.09 M(+20.8%) |
| June 2017 | - | -$15.38 M(+24.2%) | -$44.77 M(+21.6%) |
| Mar 2017 | - | -$12.38 M(+19.0%) | -$36.82 M(+21.2%) |
| Dec 2016 | -$30.39 M(+97.0%) | -$10.40 M(+57.3%) | -$30.39 M(+52.0%) |
| Sept 2016 | - | -$6.61 M(-11.0%) | -$19.99 M(+49.4%) |
| June 2016 | - | -$7.43 M(+24.9%) | -$13.38 M(+124.9%) |
| Mar 2016 | - | -$5.95 M | -$5.95 M |
| Dec 2015 | -$15.42 M | - | - |
FAQ
- What is G1 Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for G1 Therapeutics?
- What is G1 Therapeutics annual EBIT year-on-year change?
- What is G1 Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for G1 Therapeutics?
- What is G1 Therapeutics quarterly EBIT year-on-year change?
- What is G1 Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for G1 Therapeutics?
- What is G1 Therapeutics TTM EBIT year-on-year change?
What is G1 Therapeutics annual earnings before interest & taxes?
The current annual EBIT of GTHX is -$34.81 M
What is the all time high annual EBIT for G1 Therapeutics?
G1 Therapeutics all-time high annual earnings before interest & taxes is -$15.38 M
What is G1 Therapeutics annual EBIT year-on-year change?
Over the past year, GTHX annual earnings before interest & taxes has changed by +$100.61 M (+74.29%)
What is G1 Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of GTHX is -$2.74 M
What is the all time high quarterly EBIT for G1 Therapeutics?
G1 Therapeutics all-time high quarterly earnings before interest & taxes is $12.73 M
What is G1 Therapeutics quarterly EBIT year-on-year change?
Over the past year, GTHX quarterly earnings before interest & taxes has changed by -$15.47 M (-121.55%)
What is G1 Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of GTHX is -$34.02 M
What is the all time high TTM EBIT for G1 Therapeutics?
G1 Therapeutics all-time high TTM earnings before interest & taxes is -$5.95 M
What is G1 Therapeutics TTM EBIT year-on-year change?
Over the past year, GTHX TTM earnings before interest & taxes has changed by +$29.22 M (+46.20%)